Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review

Abstract

Context There is an emerging body of literature regarding multiple sclerosis (MS) in African-Americans (AA) that suggests more rapid progression and a worse prognosis in this group. A phenotype of opticospinal MS has been proposed by some publications.

Objective To determine whether AA with MS have a different clinical phenotype, different distribution of clinical subtypes, and/or different levels of disability than Caucasians (CA) with MS. Specifically, is the disability attributable to severe cerebellar disease, which limits ambulation and function? Design: Retrospective chart analyses of a patient cohort from an academic MS center.

Patients A total of 86 AA were identified with MS, 79 were followed for ≥5 years. The control group consisted of 80 randomly-selected CA with MS and similar follow-up.

Outcome measures EDSS at diagnosis, five-year follow-up, and last follow-up; time to walking assistance device; disease subtype; involved functional systems.

Results AA MS patients displayed more cerebellar dysfunction, and worse EDSS scores at diagnosis, at four to six years follow-up from diagnosis, and at last follow-up compared to the CA MS patients with similar length of follow-up. AA MS patients had earlier and more frequent gait difficulty requiring use of a cane or wheelchair. AA MS patients had a higher prevalence of primary progressive (PP) MS (22 versus 9%) and a lower rate of relapsing-remitting (RR) MS (30 versus 52%) compared to CA.

Conclusions Compared to CA patients, MS in AA is characterized by a higher incidence of cerebellar dysfunction and a more rapid accumulation of disabilities. In this cohort, AA patients had a relatively higher rate of the PPMS subtype. These data suggest the presence of fundamental differences in the clinical phenotype and the natural history of MS in AA.

Keywords

African-American cerebellar ethnicity multiple sclerosis prognosis

Get full access to this article

View all access options for this article.

References

Weinstock-Guttman B , Jacob LD , Brownscheidle CM , Baier M , Rea DF , Apatoff BR et al. Multiple sclerosis characteristics in African American patients in the New York state multiple sclerosis consortium . Mult Scler 2003; 9: 293-298 .

Cree BAC , Khan O , Bourdette D , Goodin DS , Cohen JA , Marrie RA et al. Clinical characteristics of African Americans vs. Caucasian Americans with multiple sclerosis . Neurology 2004; 63: 2039-2045 .

Kaufman MD , Johnson SK , Moyer D , Bivens J , Norton HJ. Multiple sclerosis: severity and progression rate in African Americans compared with whites . Am J Phys Med Rehabil 2003; 82: 582-590 .

Cree BC , Oksenberg JR , Barcellos LF , Khan OA , Goodin DS , Swerdlin A et al. Comparison of the clinical characteristics of African-American and Caucasian multiple sclerosis patients . Neurology 2003; 60: A61-A62 .

Buchanan RJ , Martin RA , Zuniga M , Wang S , Kim M. Nursing home residents with multiple sclerosis: comparisons of African American residents to white residents at admission . Mult Scler 2004; 10: 660-667 .

Phillips PH , Newman NJ , Lynn MJ. Optic neuritis in African-Americans . Arch Neurol 1998; 55: 186-192 .

Dean G , Bhigjee AI , Bill PL , Fritz V , Chikanza IC , Thomas JE et al. Multiple sclerosis in black South Africans and Zimbabweans . J Neurol Neurosurg Psychiatry 1994; 57: 1064-1069 .

Merle H , Cabre P , Poman G , Gerard M , Smadja D. Optical involvement in multiple sclerosis: results of a cross-sectional study with 57 patients from Martinique . J Franc d’Opthalmol 2001; 24: 829-835 .

Pokroy R , Modi G , Saffer D. Optic neuritis in an urban black African community . Eye 2001; 15: 469-473 .

10.

Traherne JA , Barcellos LF , Sawcer, Compston A , Ramsay PP , Hauser SL et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15 . Hum Mol Gene 2006; 15: 155-161 .

11.

Oksenberg JR , Barcellos LF , Cree BA , Baranzini SE , Bugawan TL , Khan O et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans . Am J Hum Genet 2004; 74: 160-167 .

12.

Morariu MA , Linden M. Multiple sclerosis in American blacks . Acta Neurol Scand 1980; 62: 180-187 .

13.

Wallin MT , Page WF , Kurtzke JF. Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis . Brain 2000; 123: 1677-1687 .

14.

Riise T , Gronning M , Fernandez O , Lauer K , Midgard R , Miderhoud JM et al. Early prognostic factors for disability in multiple sclerosis: a European multi-center study . Acta Neurol Scand 1992; 85: 212-218 .

15.

Izquierdo G , Quesada MA , Navarro G , Aguilar J , Rodriguez Moreno E , Giron JM et al. Progression of functional disability in 70 patients with multiple sclerosis . Neurologia 1991; 6: 170-174 .

16.

Weinshenker BG , Rice GP , Noseworthy JH , Carriere W , Baskerville J , Ebers GC. The natural history of multiple sclerosis: a geographically based study . Brain 1991; 114: 1045-1056 .

17.

Citterio A , Azan G , Bergamaschi R , Erbetta A , Cosi V. Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients . Neuroepidemiology 1989; 8: 249-253 .

18.

Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in northeast Scotland . J Neurol Neurosurg Psychiatry 1987; 50: 523-531 .

19.

Langdon DW , Thompson AJ. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome . Mult Scler 1999; 5: 94-100 .

20.

Alusi SH , Glickman S , Aziz TZ , Bain PG. Tremor in multiple sclerosis . J Neurol Neurosurg Psychiatry 1999; 66: 131-134 .

21.

Modi G , Mochan A , Modi M , Saffer D. Demyelinating disorder of the central nervous system occurring in black South Africans . J Neurol Neurosurg Psychiatry 2001; 70: 500-505 .

22.

Cabre P , Heinzlef O , Merle H , Buisson GG , Bera O , Bellance R et al. MS and neuromyelitis optica in Martinique (French West Indies) . Neurology 2001; 56: 507-514 .

23.

Cree BC , Goodin DS , Oksenberg JR , Barcellos LF , Hauser SL. Multiple sclerosis disease activity in patients of different ethnic origin: data from the EVIDENCE trial . Neurology 2003; 60: A61-A61 .

24.

Cree BAC , Al-Sabbagh AA , Bennett R , Goodin D. Response to interferon beta-1a treatment in African American multiple sclerosis patients . Arch Neurol 2005; 62: 1681-1683 .

25.

Sundstrom P , Svenningsson A , Nystrom L , Forsgren L. Clinical characteristics of multiple sclerosis in Vasterbotten County in northern Sweden . J Neurol Neurosurg Psychiatry 2004; 75: 711-716 .

26.

Pittock SJ , Mayr WT , McClelland RL , Jorgensen NW , Weigand SD , Noseworthy JH et al. Disability profile of MS did not change over 10 years in a population-based prevalence cohort . Neurology 2004; 62: 601-606 .

27.

Benedikz J , Stefansson M , Guomundsson J , Jonas-dottir A , Fossdal R , Gulcher J et al. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study . Clin Neurol Neurosurg 2002; 104: 208-210 .

28.

Howard G. Howard VJ. Ethnic disparities in stroke: the scope of the problem . Ethnic Dis 2001; 11: 761-768 .

29.

Lynch GF , Gorelick PB. Stroke in African Americans . Neurol Clin 2000; 18: 273-290 .

30.

Arbuckle MR , James JA , Dennis GJ , Rubertone MV , McClain MT , Kim XR et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus . Lupus 2003; 12: 99-106 .

31.

Bastian HM , Roseman JM , McGwin G , Alarcon GS , Friedman AW , Fessler BJ et al. Systemic lupus in three ethnic groups. XII risk factors for lupus nephritis after diagnosis . Lupus 2002; 11: 152-160 .

32.

Alarcon GS , McGwin G , Petri M , Reveille JD , Ramsey-Goldman R , Kimberly RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE . Lupus 2002; 11: 95-101 .

33.

De Jesus MA , Fujita M , Kim KS , Goldson AL. Retrospective analysis of breast cancer among young African American females . Breast Cancer Res Treat 2003; 78: 81-87 .

34.

Govindarajan R , Shah RV , Erkman LG , Hutchins LF. Racial difference in the outcome of patients with colorectal carcinoma . Cancer 2003; 97: 493-498 .

35.

Wu J , Metz C , Xu X , Abe R , Gibson AW , Edberg JC et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African-American systemic lupus erythematosus patients . J Immunol 2003; 170: 132-138 .

36.

Oates JC , Levesque MC , Hobbs MR , Smith EG , Molano ID , Page GP et al. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in African-Americans . J Rheum 2003; 30: 60-67 .

37.

Sullivan KE , Jawad AF , Piliero LM , Kim N , Luan X , Goldman D et al. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus . Rheumatology 2003; 42: 446-452 .

38.

Kaufman KM , Rankin J , Harley IT , Kelly JA , Harley JB , Scofield RH. A genetic marker within the CD44 gene confirms linkage at 11p13 in African-American families with lupus stratified by thrombocytopenia, but genetic association with CD44 is not present . Genes Immunol 2002; 3: S86-S88 .